Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Shanghai Pharmaceuticals purchased another 11% of...
Biohit Oyj, a Finnish diagnostics company, and Anhui...
Tianjin Weikai obtained exclusive China rights to...
JenaValve Technology, a German company that has developed...
MicroConstants China, a Beijing area CRO, has in-licensed...
Stratpharma, a Swiss company focused on dermatology...
Amgen has signed a memorandum of understanding with...
Amgen signed a MOU with ShanghaiTech University under...
Hutchison MediPharma, which is majority owned by Chi-Med,...
BGI Health, the human health unit of China sequencing...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
